CHINA-BIOTICS, INC company info

CIK 1271057
IRS Number 980393071
State of incorporation DE
Business address NO 999 NINGQIAO ROAD, JINQIAO EXPORT PRO
PUDONG
SHANGHAI
F4
201206
Mail address NO 999 NINGQIAO ROAD, JINQIAO EXPORT PRO
PUDONG
SHANGHAI
F4
201206

Short summary

CHINA-BIOTICS, INC is a China company, with head office located at No 999 Ningqiao Road, Jinqiao Export Pro Shanghai, China 201206. The company achieved a record breaking net income in 2010 - 36.94 million USD. In 2012 the company owned a total of 281.20 million USD worth of assets, including 156.02 million USD worth of current assets. The company amassed the most assets last year, totalling up to 281.20 million USD.

CHINA-BIOTICS, INC Income Statement

Name [in Millions USD]200720082009201020112012Trends
Gross Profit 38.0057.2969.8725.5546.71
Research and development 3.233.676.735.084.85
Operating Income (Loss) 21.7835.2835.733.6016.31
Interest expense 004.930.340.65
Income Tax Expense (Benefit) 5.167.798.982.833.82
Net income 19.9715.6536.942.7815.38

CHINA-BIOTICS, INC Balance Sheet

Name [in Millions USD]200720082009201020112012Trends
Cash and cash equivalents 64.3170.82159.75157.7550.6778.02
Accounts Receivable, Net, Current 21.015.0930.6124.33
Inventories 1.103.412.183.34
Property, Plant and Equipment, Gross 97.50128.80
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 17.6223.63
Total assets 232.93231.40256.22281.20
Current assets 181.95166.6086.16156.02
Accounts payable 5.851.881.751.60
Taxes Payable, Current 28.9929.0631.4832.14
Total current liabilities 76.7639.1547.1256.29
Long-term Debt 7.9115.96
Total liabilities 41.2951.0856.98
Common Stock, Value, Issued 0.000.000.000.00
Retained Earnings (Accumulated Deficit) 65.44100.32110.25120.69
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.947.9212.5617.18

CHINA-BIOTICS, INC Cash Flow

Name [in Millions USD]200720082009201020112012Trends
Net income 19.9715.6536.942.7815.38
Depreciation 1.721.914.593.674.63
Depreciation and amortization 3.724.63
Deferred Income Tax Expense (Benefit) -0.31-1.53
Accounts receivable 0.926.534.327.60-4.03
Inventories 0.140.160.620.100.27
Accounts payable 0.042.92-0.55-2.75-1.52
Net Cash Provided by (Used in) Operating Activities 23.6429.5325.791.2923.97
Payments to Acquire Productive Assets 0.8100
Net Cash Provided by (Used in) Investing Activities -17.48-13.77-15.22-83.93-22.52
Proceeds from Issuance of Common Stock 074.910
Net Cash Provided by (Used in) Financing Activities 1.4170.11-25.0012.193.72
Cash and Cash Equivalents, Period Increase (Decrease) 6.5184.76-11.59-73.905.78